Yuen MF - Search Results

1

Prevention of hepatocellular carcinoma in hepatitis B virus infection.

Lim SG, Mohammed R, Yuen MF, Kao JH. Lim SG, et al. Among authors: yuen mf. J Gastroenterol Hepatol. 2009 Aug;24(8):1352-7. doi: 10.1111/j.1440-1746.2009.05985.x. J Gastroenterol Hepatol. 2009. PMID: 19702903 Review.

2

Antituberculosis drug-related liver dysfunction in chronic hepatitis B infection.

Wong WM, Wu PC, Yuen MF, Cheng CC, Yew WW, Wong PC, Tam CM, Leung CC, Lai CL. Wong WM, et al. Among authors: yuen mf. Hepatology. 2000 Jan;31(1):201-6. doi: 10.1002/hep.510310129. Hepatology. 2000. PMID: 10613746

3

Profound suppression of hepatitis B virus replication with lamivudine.

Lai CL, Yuen MF. Lai CL, et al. Among authors: yuen mf. J Med Virol. 2000 Jul;61(3):367-73. doi: 10.1002/1096-9071(200007)61:3<367::aid-jmv15>3.0.co;2-a. J Med Virol. 2000. PMID: 10861648 Review.

4

Natural history of chronic hepatitis B virus infection.

Yuen MF, Lai CL. Yuen MF, et al. J Gastroenterol Hepatol. 2000 May;15 Suppl:E20-4. doi: 10.1046/j.1440-1746.2000.02123.x. J Gastroenterol Hepatol. 2000. PMID: 10921377

5

Factors associated with hepatitis B virus DNA breakthrough in patients receiving prolonged lamivudine therapy.

Yuen MF, Sablon E, Hui CK, Yuan HJ, Decraemer H, Lai CL. Yuen MF, et al. Hepatology. 2001 Oct;34(4 Pt 1):785-91. doi: 10.1053/jhep.2001.27563. Hepatology. 2001. PMID: 11584376 Clinical Trial.

6

Significance of hepatitis B genotype in acute exacerbation, HBeAg seroconversion, cirrhosis-related complications, and hepatocellular carcinoma.

Yuen MF, Sablon E, Yuan HJ, Wong DK, Hui CK, Wong BC, Chan AO, Lai CL. Yuen MF, et al. Hepatology. 2003 Mar;37(3):562-7. doi: 10.1053/jhep.2003.50098. Hepatology. 2003. PMID: 12601354

7

Clinical outcome and virologic profiles of severe hepatitis B exacerbation due to YMDD mutations.

Yuen MF, Kato T, Mizokami M, Chan AO, Yuen JC, Yuan HJ, Wong DK, Sum SM, Ng IO, Fan ST, Lai CL. Yuen MF, et al. Among authors: yuen jc. J Hepatol. 2003 Nov;39(5):850-5. doi: 10.1016/s0168-8278(03)00388-x. J Hepatol. 2003. PMID: 14568270

8

Hepatitis B virus genotypes B and C do not affect the antiviral response to lamivudine.

Yuen MF, Wong DK, Sablon E, Yuan HJ, Sum SM, Hui CK, Chan AO, Wang BC, Lai CL. Yuen MF, et al. Antivir Ther. 2003 Dec;8(6):531-4. Antivir Ther. 2003. PMID: 14760886

9

HBsAg seroclearance in chronic hepatitis B in the Chinese: virological, histological, and clinical aspects.

Yuen MF, Wong DK, Sablon E, Tse E, Ng IO, Yuan HJ, Siu CW, Sander TJ, Bourne EJ, Hall JG, Condreay LD, Lai CL. Yuen MF, et al. Hepatology. 2004 Jun;39(6):1694-701. doi: 10.1002/hep.20240. Hepatology. 2004. PMID: 15185311

10

Epidemiological study of hepatitis B virus genotypes, core promoter and precore mutations of chronic hepatitis B infection in Hong Kong.

Yuen MF, Sablon E, Tanaka Y, Kato T, Mizokami M, Doutreloigne J, Yuan HJ, Wong DK, Sum SM, Lai CL. Yuen MF, et al. J Hepatol. 2004 Jul;41(1):119-25. doi: 10.1016/j.jhep.2004.03.004. J Hepatol. 2004. PMID: 15246217

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

617 results

Search Page

Filters